Syra Health (NASDAQ:SYRA – Get Free Report) is projected to release its Q3 2026 results before the market opens on Tuesday, November 3rd. Analysts expect the company to announce earnings of ($0.09) per share and revenue of $2.20 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Tuesday, November 3, 2026 at 4:00 PM ET.
Syra Health (NASDAQ:SYRA – Get Free Report) last issued its quarterly earnings results on Tuesday, August 11th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.11. The firm had revenue of $2.39 million for the quarter, compared to analyst estimates of $2.20 million. Syra Health had a negative return on equity of 131.94% and a negative net margin of 54.90%.
Syra Health Stock Up 0.6%
Syra Health stock opened at $0.89 on Thursday. The business has a 50 day moving average price of $0.87 and a two-hundred day moving average price of $0.51. The stock has a market cap of $12.33 million, a price-to-earnings ratio of -1.37 and a beta of 2.91. Syra Health has a 12 month low of $0.06 and a 12 month high of $1.15.
Syra Health Company Profile
Syra Health Corp. is a healthcare technology and services company focused on improving access, delivery and outcomes across the U.S. healthcare system. The company develops solutions for behavioral and mental health, population health management, healthcare education and workforce needs.
Its offerings are designed to support healthcare providers, government agencies, employers and other organizations. Syra Health combines technology, data and professional services to assist with areas such as care coordination, health education, clinical workforce development, behavioral health programs and population health initiatives.
Based in Carmel, Indiana, Syra Health was established in the early 2020s and serves clients in the United States.
Further Reading
- Five stocks we like better than Syra Health
- Garmin Raises Its Profit OutlookâCan the Stock Reach New Highs?
- Why Rising Rates Could Break the Bull Market Before AI Spending Can Save It
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
Receive News & Ratings for Syra Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syra Health and related companies with MarketBeat.com's FREE daily email newsletter.
